FDA Investigator: Amir Alavi

- Amir Alavi first started conducting FDA inspections in 2002, with the last inspection in 2024. Over that time, Amir Alavi has conducted 55 inspections at 51 companies across 50 sites.

Get Amir Alavi's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Baxter Healthcare Corporation, Jayuya | 2024

Out-of-stock
Amir Alavi
Human Drugs Form 483

FDA 483 B. Braun Medical Inc., Irvine | 2023

Out-of-stock
Amir Alavi
Human Drugs Form 483

FDA 483 Organo Sintesis, S.A. De C.V., Capulhuac | 2023

Out-of-stock
Amir Alavi
Human Drugs Form 483

FDA 483 Pyramid Laboratories, Inc., Costa Mesa | 2021

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Atlas Analytical Inc., Brooksville | 2019

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Corden Pharma Latina S.p.A., Sermoneta | 2019

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 swissfillon AG, Visp | 2019

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Redox S.r.l., Monza | 2019

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Teva Parenteral Manufacturing, Irvine | 2019

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Eumedica Pharmaceuticals Industries SL, Silvota (Llanera-Pol. Industrial) | 2018

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Genentech, Inc., Vacaville | 2018

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Shadow Holdings DBA Bocchi Labs, Santa Clarita | 2018

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Corden Pharma Latina S.p.A., Sermoneta | 2017

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Amphastar Pharmaceuticals, Inc., Rancho Cucamonga | 2017

Out-of-stock
Amir Alavi
Human Drug Form 483

FDA 483 Allergan Inc, Irvine | 2008

Out-of-stock
Amir Alavi
Human Drug Form 483

Co-Investigators (53)